The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review
Pooled result · HbA1cResult — go to the resultWMD −0.43 %Authors' conclusion
Compared with usual care, CGM/is-CGM can reduce HbA1c, but most studies had notable biases, were short duration, unmasked, and were sponsored by industry. Further research needs to confirm the long-term benefits of CGM/is-CGM in primary care.
Study context
- Population
- Patients with DM in primary care; studies with <20 participants, specialty care only or hospitalized participants excluded
- Participants
- 4,006 patients10 studies
- Comparison
- Continuous glucose monitoring (CGM)/intermittently scanned CGM (is-CGM) vs usual care in primary care
- Outcome
- HbA1c (weighted mean difference)
Methodological detailsnarrative synthesis, weighted mean difference of HbA1c, Search of seven databases, June 2021, Quality assessed with NHLBI tool and GRADE
- Narrative synthesis
- Weighted mean difference of HbA1c
- Search of seven databases, June 2021
- Quality assessed with NHLBI tool and GRADE
Pooled result
HbA1c
Weighted mean difference (WMD)
−0.43 %
As reported in the abstract
Further pooled results
TIR, TAR, TBR
- Low certainty of evidence that CGM/is-CGM improves TIR, TAR or TBR over usual care
Hypoglycemic events
- CGM can reduce hypoglycemic events
Staff/patient satisfaction
- Staff/patient satisfaction is high
Subgroup: intensive insulin therapy
- Patients with intensive insulin therapy may benefit more from CGM/is-CGM
Original publication
The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol. Published 1 February 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →